DEFA14A: Bausch Health Updates Share Ownership Disclosures Ahead of 2025 Annual Meeting

Bausch Health Companies Inc. updates its proxy statement with revised information regarding the beneficial ownership of its common shares by Carl Icahn and Paulson & Co., Inc. in preparation for the 2025 Annual Meeting of Shareholders.

Summary

• Bausch Health Companies Inc. has filed a supplement to its proxy statement with the SEC.
• The supplement provides updated information on the ownership of the company's securities by certain beneficial owners, specifically Carl C. Icahn and Paulson & Co., Inc.
• The update relates to the upcoming 2025 Annual Meeting of Shareholders scheduled for May 13, 2025.
• The changes involve replacing notes in the tabular disclosure regarding security ownership.
• Carl Icahn and associated entities may be deemed to beneficially own 34,721,118 Common Shares.
• Icahn also has long economic exposure to an additional 90,720,000 Common Shares through cash-settled equity swap agreements maturing on February 28, 2028.
• Paulson & Co., Inc. has sole voting and dispositive power with respect to 26,439,035 Common Shares.
• Paulson & Co., Inc. also owns $29 million in principal amount of the company's 5.0% senior unsecured notes due February 2029 and $21 million in principal amount of its 7.25% senior unsecured notes due May 2029.
• Previously submitted proxy cards or voting instructions remain valid unless shareholders wish to change their votes.
• The proxy statement and supplement are available on www.proxyvote.com and www.bauchhealth.com.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing, so the sentiment is neutral to slightly positive due to increased transparency. It provides clarity on the ownership structure, which is generally viewed favorably by investors.

Future Outlook

The document does not contain specific forward-looking statements beyond the scheduled Annual Meeting.

Industry Context

This announcement is typical for publicly traded companies as they prepare for annual shareholder meetings, ensuring transparency regarding significant shareholders and their holdings.

Comparison to Industry Standards

• Proxy statement updates regarding beneficial ownership are standard practice for publicly traded companies like Bausch Health.
• Companies such as Valeant (previous name of Bausch Health) and Pershing Square Capital Management (Bill Ackman) have had similar disclosures in the past.
• The level of detail regarding equity swap agreements is consistent with regulatory requirements for disclosing economic exposure.
• The disclosure of Paulson & Co.'s holdings of senior unsecured notes is also a common practice to provide a complete picture of their financial interest in the company.

Stakeholder Impact

• Shareholders are directly impacted by the information regarding beneficial ownership as it can influence voting outcomes and corporate control.
• The disclosure of debt holdings by Paulson & Co. provides additional transparency for creditors.

Next Steps

• Shareholders should review the updated proxy statement and supplement.
• Shareholders should cast their votes for the agenda items to be considered at the Annual Meeting on May 13, 2025.

Key Dates

Keywords

proxy statement, beneficial ownership, Bausch Health, Carl Icahn, Paulson & Co., shareholders, annual meeting, securities, voting rights, equity swap agreements, senior unsecured notes